SCHEDULE 14A INFORMATION

Company

NovaBay Pharmaceuticals, Inc.

Filed

April 25, 2011

Period of Report

June 9, 2011

Accession Number

0001437749-11-002529

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →